āagman

Not investment advice. Data and computed figures, for information only.

Healthcare Global Enterprises Ltd

NSE: HCG
₹590.60
+₹3.65 (+0.62%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹8,797 Cr
CMP
₹590.60
52-wk High / Low
₹805 / 513
P/E
183.0
P/B
6.6
Book Value
₹89.2
Div Yield
0.00%
ROCE
8.0%
ROE
2.5%
Face Value
₹10
D/E
1.30

Price−14.4% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
6
/ 9
6 of 9 F-score tests passed
Graham Number
₹43
√(22.5 × EPS × book value per share)
ROIC
6.0%
vs 11.2% sector median
Cash flow to profit
15.09
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−6
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
2.5%
ROE × earnings retention ratio
ROE stability
1.5
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −0.03DII +0.29
Latest quarter vs the previous one
Cash-accrual divergence
−8.7%
of assets
Low = accruals track cash flow
Strengths
Watch-outs
−Latest ROCE of 8% trails the sector median of 17%
−Borrowings are up 435.5% since FY2016 (324 to 1735)
−Price trades below its 200-day moving average (0.9x)
−Promoter holding fell by 7.2pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales461487470495526554559585613647633652695
Expenses386402391403435451470480505524524527573
Operating Profit748579929110288106108123110125122
OPM %16.1%17.5%16.8%18.6%17.3%18.4%15.7%18.1%17.6%19.0%17.4%19.2%17.6%
Other Income336991161083−10−1813
Interest26272927343641444544454340
Depreciation41434446475057585863616370
Profit before tax111811281928−3141220−6125
Net Profit411323142187621−8416
EPS (₹)0.520.920.391.440.821.220.470.500.321.09−0.630.150.92

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5195847008299761,0921,0091,3951,6911,9082,2182,5382,627
Expenses4434995957138649368871,1611,3941,5811,8352,0802,147
Operating Profit7685105116112157122234297327384459480
OPM %14.6%14.6%15.0%14.0%11.5%14.4%12.1%16.8%17.6%17.1%17.3%18.1%18.3%
Other Income0−210251010−72110152439−11−13
Interest343823427013811998104109155177171
Depreciation3944577185148159158163174211244257
Profit before tax303527−33−119−229884568572740
Net Profit522317−31−125−221391841492333
EPS (₹)0.11−0.162.442.23−2.66−11.36−14.583.651.993.273.010.921.53

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital708586878889125139139139139149—
Reserves2103413474283892935727317216867831,183—
Borrowings3493244204646581,3479779159011,2741,8371,735—
Other Liabilities147294372461515518357433549601780853—
Total Liabilities7761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,920—
Fixed Assets5285836858289701,6461,3821,5471,5531,7582,4422,462—
CWIP4212114817415346302218832519—
Investments0641153493426910101114—
Other Assets2052753813854785205936417308501,0621,426—
Total Assets7761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,920—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6073919898130121220252285317347
Cash from Investing Activity−79−204−210−283−238−101−171125−133−226−488−177
Cash from Financing Activity222168916184−58112−155−140−64−42241
Net Cash Flow285−29−24−56−3062190−22−5−213410

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %7.06.07.06.03.01.0−1.05.08.09.09.08.0
ROE %———————————2.5
EPS (₹)0.11−0.162.442.23−2.66−11.36−14.583.651.993.273.010.92
Book Value (₹)———————————89.2
Face Value (₹)———————————10
P/E———————————183.0
Div Yield %———————————0.00
NPM %1.00.33.22.0−3.1−11.3−23.62.61.12.12.20.9
OPM %15.015.015.014.011.014.012.017.018.017.017.018.0
D/E1.250.760.970.901.383.531.401.051.051.541.991.30
P/B———————————6.6

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+16.0%
5 years+20.0%
3 years+14.0%
TTM+14.0%
Compounded profit growth
10 years+39.0%
5 years+18.0%
3 years−1.0%
TTM+30.0%
Stock price CAGR
10 years+10.0%
5 years+19.0%
3 years+17.0%
Last year−14.0%
Return on equity
10 years−1.0%
5 years4.0%
3 years4.0%
Last year3.0%

Shareholding pattern

As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters24.61%24.61%24.39%24.04%24.11%23.90%70.71%71.43%71.37%71.28%71.22%64.21%64.21%
FIIs0.00%0.00%15.63%35.57%33.08%25.05%6.34%6.99%6.37%6.74%2.44%2.76%2.73%
DIIs56.70%56.70%28.25%22.71%25.10%29.65%9.62%5.86%5.53%8.52%12.48%18.91%19.20%
Government—————————————
Public18.69%18.69%31.73%17.67%17.72%21.40%13.33%15.73%16.71%13.45%13.86%14.15%13.86%
No. of shareholders19,04019,04010,8009,7959,8719,99313,89123,66328,85827,19545,39447,64948,905
Change since Jun 2023 (pp)
Promoters +39.60FIIs +2.73DIIs −37.50Public −4.83

Documents

As of 11 Oct 2026
Announcements
Announcement under Regulation 30 (LODR)-AcquisitionClosure of Trading WindowShareholder Meeting / Postal Ballot-Scrutinizer''s ReportShareholder Meeting / Postal Ballot-Outcome of AGMAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026PPTDec 2025TranscriptDec 2025PPTDec 2025Recording

Corporate actions

As of 2 Mar 2026
2 Mar 2026RIGHTSRights 1:17 @ Premium Rs 502/-—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman